Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Phylogica
Phylogica
Activities:
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Phylogica signs deal with UK biotech to identify and develop cancer drugs
Takes a 7.5% stake in PhoreMost, based in Cambridge
Research & Development
Phylogica enters into research and licensing agreement with Genentech
Perth, Australia-based company will receive an upfront payment of US$500,000
Research & Development
Phylogica expands peptide drug conjugates pact with Janssen
Australian firm has received an undisclosed payment to fund additional research
Research & Development
Phylogica enters peptide agreement with Janssen Biotech
To identify cell-penetrating Phylomer peptides
Research & Development
Phylogica forms target discovery spin-off
Sets up new venture called Phenomica with University of Cambridge in the UK
Research & Development
Phylogica completes first stage of collaboration with Roche
Receives undisclosed milestone payment
Research & Development
Phylogica to collaborate with Pfizer
To discover novel peptide-based vaccines
Subscribe now